search
Back to results

Safety and Efficacy of the Vibrant Soundbridge (VSB) for Mixed and Conductive Hearing Losses (VSBRW)

Primary Purpose

Hearing Loss

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Vibrant Soundbridge
Sponsored by
Med-El Corporation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hearing Loss focused on measuring sensorineural hearing loss, conductive hearing loss, mixed hearing loss

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adults, 18 years of age or older at time of implantation
  • English as the primary language
  • Appropriate motivation and expectation levels
  • Geographically and physically able to return to the investigational center for scheduled evaluations and follow-up appointments.
  • At least a 28-day unsuccessful hearing aid trial (within the past 24 months prior to enrolment).
  • Persons who after being informed that a different hearing aid than the one they currently have may provide improved hearing, still request an implant.
  • Ability to undergo general anesthesia
  • Audiological tests suggest either a conductive or mixed hearing loss. The non-implanted ear may fall outside these criteria; however, threshold levels may not be worse than severe sloping to profound.
  • Conductive Hearing Loss
  • Pure-tone bone-conduction threshold levels in the ear to be implanted shall fall at or within the levels stated below. There should be an air-bone gap of 15 dB HL or more at three or more of the frequencies 500, 1000, 1500, 2000, 3000, and 4000 Hz. Pure-tone air-conduction levels should indicate the presence of at least a moderate hearing loss of at least 41 dB HL. Air conduction levels are not limited on the upper end.
  • Upper Limits of Bone Conduction Thresholds for Conductive Hearing Loss Frequency (kHz) 0.5 1.0 1.5 2.0 3.0 4.0 Bone Conduction upper limit (dBHL) <25 <25 <25 <25 <25 <25
  • Mixed Hearing Loss
  • Pure-tone bone conduction threshold levels in the ear to be implanted shall fall at or within the levels stated below. There should be an air-bone gap of 15 dB HL or more at three or more of the frequencies 500, 1000, 1500, 2000, 3000, and 4000 Hz. Bone conduction thresholds at least three of the frequencies should be 26 dB or greater. Pure-tone air-conduction thresholds should be, on average, at least moderately impaired of 41 dB or greater. Air-conduction levels are not limited on the upper end.
  • Lower and Upper Limits of Bone Conduction Thresholds for Mixed Hearing Loss Frequency (kHz) 0.5 1.0 1.5 2.0 3.0 4.0 Bone Conduction lower limit (dBHL) 0 0 0 0 0 0 Bone Conduction upper limit (dBHL) 45 50 55 65 65 65
  • Good potential for aided speech recognition as indicated by a pre-operative monosyllabic word score of > 30% in the ear to be implanted as measured under headphones at 40 dB SL or at MCL
  • Hearing aid trial with appropriately fitted hearing aids of at least 28 days duration within the past 24 months, unless the subject is unable to wear hearing aids for medical reasons
  • Most recent audiometric data, if available, judged to be of good test-retest reliability.

Exclusion Criteria:

  • Hearing loss of purely sensorineural origin
  • Retrocochlear or central auditory disorders
  • Active middle ear infection
  • Tympanic membrane perforation, ears with previously reconstructed tympanic membranes may be included
  • Bone-conduction thresholds in the ear to be implanted that have demonstrated a recent fluctuation at two or more frequencies of 15 dB in either direction in the last 6 months, as demonstrated by serial audiograms.
  • History of post-adolescent, inner-ear disorders, such as vertigo or labyrinthitis
  • Chronic or non-revisable vestibular or balance disorders
  • Middle ear infections not responsive to medical treatment
  • Skin or scalp conditions that may preclude attachment of the Audio Processor or that may interfere with the use of the Audio Processor
  • Chronic pain in or around the head
  • Current or previous use of an active hearing implant in either ear.
  • Any known physical, psychological, or emotional disorder that may interfere with the completion of scheduled follow-up evaluations
  • Developmental delays or organic brain dysfunction

Sites / Locations

  • House Ear Institute
  • Jennifer Maw, MD
  • University of Miami Ear Institute
  • Silverstein Institute
  • Ear Institute of Chicago
  • University of Kansas Medical Center
  • Midwest Ear Institute
  • Capitol Region Ear Institute
  • University of North Carolina Hospital
  • Pittsburgh Ear Associates
  • University of Texas Southwestern Medical Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Implanted

Arm Description

Implanted with Vibrant Soundbridge

Outcomes

Primary Outcome Measures

Speech Perception in Quiet (Monosyllables) in Patients Implanted With Vibrant Soundbridge
Percent correct on words in quiet at the preoperative interval compared to 6 month post operative interval.

Secondary Outcome Measures

Functional Gain Compared to Preoperative Unaided Condition in Patients Implanted With Vibrant Soundbridge.
Auditory thresholds in the soundfield at the preoperative interval compared to the 6 month postoperative interval.
Speech Perception in Noise (HINT Sentences) in Patients Implanted With Vibrant Soundbridge.
Signal to Noise Ratio for sentences at the preoperative interval compared to the 6 month interval.
Residual Hearing in Patients Implanted With Vibrant Soundbridge
Unaided hearing thresholds measured at the 10 month interval compared to the preoperative interval in order to assess any changes

Full Information

First Posted
September 5, 2008
Last Updated
September 10, 2019
Sponsor
Med-El Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT00748540
Brief Title
Safety and Efficacy of the Vibrant Soundbridge (VSB) for Mixed and Conductive Hearing Losses
Acronym
VSBRW
Official Title
Clinical Trial of the Vibrant Soundbridge as a Treatment for Conductive and Mixed Hearing Losses, Using Direct Round Window Cochlear Stimulation.
Study Type
Interventional

2. Study Status

Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
December 2007 (undefined)
Primary Completion Date
March 2014 (Actual)
Study Completion Date
March 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Med-El Corporation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this investigation is to collect feasibility data to assess the safety and efficacy of the Vibrant Soundbridge (VSB), a medical device designed to provide benefit in aided hearing thresholds, speech perception and sound quality to certain individuals with hearing loss with minimal changes in residual hearing. The VSB is currently indicated for adults with moderate-to-severe sensorineural hearing loss. Under the present investigation, adults with conductive and mixed hearing losses who are not successful users of traditional amplification will be assessed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hearing Loss
Keywords
sensorineural hearing loss, conductive hearing loss, mixed hearing loss

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Implanted
Arm Type
Experimental
Arm Description
Implanted with Vibrant Soundbridge
Intervention Type
Device
Intervention Name(s)
Vibrant Soundbridge
Other Intervention Name(s)
VSB, VSB RW, RW VSB, Round Window Stimulation
Intervention Description
Mixed and conductive hearing loss using round window stimulation
Primary Outcome Measure Information:
Title
Speech Perception in Quiet (Monosyllables) in Patients Implanted With Vibrant Soundbridge
Description
Percent correct on words in quiet at the preoperative interval compared to 6 month post operative interval.
Time Frame
6 months post initial activation
Secondary Outcome Measure Information:
Title
Functional Gain Compared to Preoperative Unaided Condition in Patients Implanted With Vibrant Soundbridge.
Description
Auditory thresholds in the soundfield at the preoperative interval compared to the 6 month postoperative interval.
Time Frame
6 months post initial activation
Title
Speech Perception in Noise (HINT Sentences) in Patients Implanted With Vibrant Soundbridge.
Description
Signal to Noise Ratio for sentences at the preoperative interval compared to the 6 month interval.
Time Frame
6 months post initial activation
Title
Residual Hearing in Patients Implanted With Vibrant Soundbridge
Description
Unaided hearing thresholds measured at the 10 month interval compared to the preoperative interval in order to assess any changes
Time Frame
10 months post initial activation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults, 18 years of age or older at time of implantation English as the primary language Appropriate motivation and expectation levels Geographically and physically able to return to the investigational center for scheduled evaluations and follow-up appointments. At least a 28-day unsuccessful hearing aid trial (within the past 24 months prior to enrolment). Persons who after being informed that a different hearing aid than the one they currently have may provide improved hearing, still request an implant. Ability to undergo general anesthesia Audiological tests suggest either a conductive or mixed hearing loss. The non-implanted ear may fall outside these criteria; however, threshold levels may not be worse than severe sloping to profound. Conductive Hearing Loss Pure-tone bone-conduction threshold levels in the ear to be implanted shall fall at or within the levels stated below. There should be an air-bone gap of 15 dB HL or more at three or more of the frequencies 500, 1000, 1500, 2000, 3000, and 4000 Hz. Pure-tone air-conduction levels should indicate the presence of at least a moderate hearing loss of at least 41 dB HL. Air conduction levels are not limited on the upper end. Upper Limits of Bone Conduction Thresholds for Conductive Hearing Loss Frequency (kHz) 0.5 1.0 1.5 2.0 3.0 4.0 Bone Conduction upper limit (dBHL) <25 <25 <25 <25 <25 <25 Mixed Hearing Loss Pure-tone bone conduction threshold levels in the ear to be implanted shall fall at or within the levels stated below. There should be an air-bone gap of 15 dB HL or more at three or more of the frequencies 500, 1000, 1500, 2000, 3000, and 4000 Hz. Bone conduction thresholds at least three of the frequencies should be 26 dB or greater. Pure-tone air-conduction thresholds should be, on average, at least moderately impaired of 41 dB or greater. Air-conduction levels are not limited on the upper end. Lower and Upper Limits of Bone Conduction Thresholds for Mixed Hearing Loss Frequency (kHz) 0.5 1.0 1.5 2.0 3.0 4.0 Bone Conduction lower limit (dBHL) 0 0 0 0 0 0 Bone Conduction upper limit (dBHL) 45 50 55 65 65 65 Good potential for aided speech recognition as indicated by a pre-operative monosyllabic word score of > 30% in the ear to be implanted as measured under headphones at 40 dB SL or at MCL Hearing aid trial with appropriately fitted hearing aids of at least 28 days duration within the past 24 months, unless the subject is unable to wear hearing aids for medical reasons Most recent audiometric data, if available, judged to be of good test-retest reliability. Exclusion Criteria: Hearing loss of purely sensorineural origin Retrocochlear or central auditory disorders Active middle ear infection Tympanic membrane perforation, ears with previously reconstructed tympanic membranes may be included Bone-conduction thresholds in the ear to be implanted that have demonstrated a recent fluctuation at two or more frequencies of 15 dB in either direction in the last 6 months, as demonstrated by serial audiograms. History of post-adolescent, inner-ear disorders, such as vertigo or labyrinthitis Chronic or non-revisable vestibular or balance disorders Middle ear infections not responsive to medical treatment Skin or scalp conditions that may preclude attachment of the Audio Processor or that may interfere with the use of the Audio Processor Chronic pain in or around the head Current or previous use of an active hearing implant in either ear. Any known physical, psychological, or emotional disorder that may interfere with the completion of scheduled follow-up evaluations Developmental delays or organic brain dysfunction
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David Foyt, MD
Organizational Affiliation
Capital Region Ear Institute
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jose Fayad, MD
Organizational Affiliation
House Ear Institute
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jennifer Maw, MD
Organizational Affiliation
Jennifer Maw, MD
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Robert Cullen, MD
Organizational Affiliation
Midwest Ear Institute
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Douglas Chen, MD
Organizational Affiliation
Pittsburgh Ear Associates
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jack Wazen, MD
Organizational Affiliation
Silverstein Institute
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Hinrich Staecker, MD, PhD
Organizational Affiliation
University of Kansas Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Fred Telischi, MD
Organizational Affiliation
University of Miami
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Craig Buchman, MD
Organizational Affiliation
University of North Carolina Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Peter Roland, MD
Organizational Affiliation
University of Texas Southwestern Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Richard Wiet, MD
Organizational Affiliation
Ear Institute of Chicago
Official's Role
Principal Investigator
Facility Information:
Facility Name
House Ear Institute
City
Los Angeles
State/Province
California
ZIP/Postal Code
90057
Country
United States
Facility Name
Jennifer Maw, MD
City
San Jose
State/Province
California
ZIP/Postal Code
95124-3910
Country
United States
Facility Name
University of Miami Ear Institute
City
Miami
State/Province
Florida
ZIP/Postal Code
33136
Country
United States
Facility Name
Silverstein Institute
City
Sarasota
State/Province
Florida
ZIP/Postal Code
34239
Country
United States
Facility Name
Ear Institute of Chicago
City
Hinsdale
State/Province
Illinois
ZIP/Postal Code
60521
Country
United States
Facility Name
University of Kansas Medical Center
City
Kansas City
State/Province
Kansas
ZIP/Postal Code
66160
Country
United States
Facility Name
Midwest Ear Institute
City
Kansas City
State/Province
Missouri
ZIP/Postal Code
64111
Country
United States
Facility Name
Capitol Region Ear Institute
City
Slingerlands
State/Province
New York
ZIP/Postal Code
12159
Country
United States
Facility Name
University of North Carolina Hospital
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27514
Country
United States
Facility Name
Pittsburgh Ear Associates
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15212
Country
United States
Facility Name
University of Texas Southwestern Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
17062502
Citation
Colletti V, Soli SD, Carner M, Colletti L. Treatment of mixed hearing losses via implantation of a vibratory transducer on the round window. Int J Audiol. 2006 Oct;45(10):600-8. doi: 10.1080/14992020600840903.
Results Reference
background
PubMed Identifier
17065833
Citation
Kiefer J, Arnold W, Staudenmaier R. Round window stimulation with an implantable hearing aid (Soundbridge) combined with autogenous reconstruction of the auricle - a new approach. ORL J Otorhinolaryngol Relat Spec. 2006;68(6):378-85. doi: 10.1159/000095282. Epub 2006 Oct 26.
Results Reference
background

Learn more about this trial

Safety and Efficacy of the Vibrant Soundbridge (VSB) for Mixed and Conductive Hearing Losses

We'll reach out to this number within 24 hrs